BN Business News
Añadir empresa →
Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.

Negocios · 16/4/20261 min de lectura

Medical Devices; Ear, Nose, and Throat Devices; Classification of the Transcutaneous Electrical Nerve Stimulator for the Relief of Congestion

Traducción automática local · Idioma original de la fuente

Resumen

The Food and Drug Administration (FDA, the Agency, or we) is classifying the transcutaneous electrical nerve stimulator for the relief of congestion into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the transcutaneous electrical nerve stimulator for the relief of congestion. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →